Surveillance of the Eye and Vision in Clinical Trials of CP-675,206 for Metastatic Melanoma

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

2002 • 2,781 citations

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1996 • 2,073 citations

Progress in human tumour immunology and immunotherapy

2001 • 1,327 citations

Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment

1990 • 1,021 citations

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

2005 • 997 citations

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

2003 • 981 citations

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

2005 • 584 citations

Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon

2006 • 555 citations

Prognostic significance of autoimmunity during treatment of melanoma with interferon

2011 • 515 citations

A new American Joint Committee on Cancer staging system for cutaneous melanoma

2000 • 438 citations

Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.

2000 • 438 citations

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

2004 • 432 citations

Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer

2005 • 350 citations

Clinical and Immunologic Characteristics of Melanoma-Associated Retinopathy Syndrome: Eleven New Cases and a Review of 51 Previously Published Cases

2001 • 240 citations

Paraneoplastic Retinopathies and Optic Neuropathies

2003 • 210 citations

Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade in Patients with Metastatic Melanoma

2004 • 157 citations

Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.

2000 • 114 citations

Severe course of cutaneous melanoma associated paraneoplastic retinopathy.

1995 • 74 citations

Autoantibodies to transducin in a patient with melanoma-associated retinopathy

2002 • 65 citations

Retinal findings in melanoma-associated retinopathy

2001 • 54 citations

Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma

2001 • 45 citations

Hypopigmentation Associated With an Adenovirus-Mediated gp100/MART-1–Transduced Dendritic Cell Vaccine for Metastatic Melanoma

2002 • 45 citations

Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV

2005 • 44 citations

Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.

2002 • 33 citations

Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma

2004 • 7 citations

Antigen-specific T cell responses in patients with melanoma treated with the CTLA4 blocking mAb ticilimumab

2006 • 6 citations